The Effects of Alzheimer's: Gender, Race, & Ethnicity

Main Article Content

Kenya Rodriguez
Marcela Trevino
Galilea Castro
Hannah Rodriguez Rodriguez
Nah'Re Royal
Grace Ortiz
Jorge Garza
Selena Aleman
Allison Alvarez

Keywords

Alzheimer's Disease, Dementia, Gender, Race, Hispanics, African Americans, Behavior

Abstract

N/A

Abstract 410 | PDF Downloads 216

References

1. Yang, H. D., Kim, D. H., Lee, S. B., & Young, L. D. (2016). History of Alzheimer's Disease. Dementia and neurocognitive disorders, 15(4), 115–121. https://doi.org/10.12779/dnd.2016.15.4.115
2. National Institute on Aging. (2021, July 8). What Is Alzheimer’s Disease? National Institute on Aging.
3. Torrico, T. J., & Abdijadid, S. (2019, February 10). Neuroanatomy, Limbic System. Nih.gov; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK538491/
4. National Institute on Aging. (2017, May 17). Managing Personality and Behavior Changes in Alzheimer's. National Institute on Aging.
5. Cleveland Clinic. (2019, March 18). Alzheimer’s Disease: Symptoms, Causes, Treatments. Cleveland Clinic.
6. Grabher B. J. (2018). Effects of Alzheimer Disease on Patients and Their Family. Journal of nuclear medicine technology, 46(4), 335–340.
7. U.S. burden of Alzheimer’s disease, related dementias to double by 2060. (2019). Centers for Disease Control and Prevention.
8. Understanding the Relationship Between High Blood Pressure and Type 2 Diabetes. (2018, November 28). Canopy Health.
9. MD, A. E. B. (2022, January 20). Why are women more likely to develop Alzheimer’s disease? Harvard Health. Levine, H. (n.d.). Women More Likely Than Men to Develop Alzheimer’s. AARP.
10. What are Amyloid Plaques? (2014, January 17). News-Medical.net.
11. Hedman, S. A., Fuzy, J. L., & Rymer, S. A. (2018). Hartman's Nursing Assistant Care: The Basics. Albuquerque, New Mexico: Hartman Publishing, Inc. 111-113
12. Mayo Clinic Staff. (2019). How Alzheimer’s drugs help manage symptoms. Mayo Clinic.
13. Mayo Clinic. (2018). Alzheimer’s disease - Diagnosis and treatment - Mayo Clinic. Mayoclinic.org.
14. Mangialasche, F., Solomon, A., Winblad, B., Mecocci, P., & Kivipelto, M. (2010). Alzheimer’s disease: clinical trials and drug development. The Lancet Neurology, 9(7), 702–716. https://doi.org/10.1016/S1474-4422(10)70119-8


15. Sun, B.-L., Li, W.-W., Zhu, C., Jin, W.-S., Zeng, F., Liu, Y.-H., Bu, X.-L., Zhu, J., Yao, X.-Q., & Wang, Y.-J. (2018). Clinical Research on Alzheimer’s Disease: Progress and Perspectives. Neuroscience Bulletin, 34(6), 1111–1118. https://doi.org/10.1007/s12264-018-0249-z
16. Kang, J. M., Yeon, B. K., Cho, S.-J., & Suh, Y.-H. (2016). Stem Cell Therapy for Alzheimer’s Disease: A Review of Recent Clinical Trials. Journal of Alzheimer’s Disease, 54(3), 879–889. https://doi.org/10.3233/jad-160406
17. Briggs, R., Kennelly, S. P., & O’Neill, D. (2016). Drug treatments in Alzheimer's disease. Clinical Medicine, 16(3), 247–253. https://doi.org/10.7861/clinmedicine.16-3-247
18. Carter, C. J. (2010). Alzheimer's disease: A pathogenetic autoimmune disorder caused by herpes simplex in a gene-dependent manner. International Journal of Alzheimer's Disease, 2010, 1–17. https://doi.org/10.4061/2010/140539
19. Shub, A., & Lappas, M. (2020). Pregestational diabetes in pregnancy: Complications, management, surveillance, and mechanisms of disease-A review. Prenatal diagnosis, 40(9), 1092–1098. https://doi.org/10.1002/pd.5718